Related Experiment Videos
Experience with oral methylprednisolone in the treatment of refractory hyperemesis gravidarum
H R Safari1, O M Alsulyman, R B Gherman
1Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles, USA.
Objective:
Our purpose was to describe the effect of oral methylprednisolone on the course of refractory hyperemesis gravidarum.
Study Design:
Patients with intractable hyperemesis gravidarum were candidates for oral methylprednisolone. Forty-eight milligrams per day was given for 3 days followed by a tapering dose over 2 weeks. If vomiting recurred after 2 weeks of therapy or during tapering, the medication was restarted or extended but not longer than 1 month total.
Results:
Seventeen of 18 patients (94%) were free of vomiting and were able to tolerate a regular diet within 3 days. Seven did not have further symptoms during their pregnancies. Nine vomited during or after tapering, but 7 of these responded to extension or reinstitution of therapy. Four of 6 patients on total parenteral nutrition at the start of therapy had a complete response within 3 days.
Conclusions:
A short course of oral methylprednisolone appears to be a reasonable therapeutic alternative for intractable hyperemesis.